Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
DIAZEPAM
Pinewood Laboratories Ltd,
5 Milligram
Tablets
1981-04-15
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0281/007/002 Case No: 2082243 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to PINEWOOD LABORATORIES LTD, T/A PINEWOOD HEALTHCARE BALLYMACARBRY, CLONMEL, CO. TIPPERARY, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product DIAZEPAM, 5 MILLIGRAM The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 25/05/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 25/05/2010_ _CRN 2082243_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Diazepam 5 mg Tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of diazepam. Also includes 141 mg of lactose monohydrate For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Yellow, circular, flat, beveled edge tablets with ‘D over 5’ and a breakline on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS STANDARD DOSAGE For optimal effect, the dosage should be carefully individualized. Treatment should begin at the lowest effective dose appropriate to the particular condition. 1. Anxiety. 2. Insomnia: Benzodiazepines are only indicated when the disor Read the complete document